PER Postgame™: The Latest from Louisville 2022 " Utilizing Recent Data to Improve Care for Patients with Peanut Allergy

Target Audience
This educational activity is directed toward allergists/immunologists, internists, pediatricians, NPs, PAs, and RNs. Other healthcare professionals involved in the management of patients with food allergy are invited to participate as well.

Activity Overview
Children with peanut allergies and their families often experience a profoundly reduced health-related quality of life. Data show that food allergy affects 4% to 7% of primary school children. A national allergy database demonstrated that peanut was the most common trigger among 105 cases of food-induced anaphylaxis. Living with peanut allergy can lead to fear and anxiety regarding the risk of exposure and reaction to the allergen.

The PER Postgame™ is an innovative and unique webcast by PER®. It is an in-depth, engaging data recap program, focusing on novel therapeutic agents and emerging treatment strategies discussed at major medical meetings. This program focuses on abstracts presented at the 2022 American College of Allergy, Asthma & Immunology (ACAAI) annual meeting.

Learning Objectives
Upon completion of this activity, you should be better able to:
Outline the quality-of-life (QoL)-related issues that patients with peanut allergies and their caregivers typically encounter
Analyze recent efficacy and safety data of novel oral immunotherapy (OIT) agents that have the potential to substantially impact outcomes in patients with peanut allergies
Design optimal treatment plans for toddlers with peanut allergies based on the latest clinical trial data findings regarding OIT agents
Implement patient education and preferences in addition to important treatment considerations regarding OIT agents into shared decision-making (SDM) models while managing patients with peanut allergies